Ivan Kruljac

727 total citations
25 papers, 183 citations indexed

About

Ivan Kruljac is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Ivan Kruljac has authored 25 papers receiving a total of 183 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Epidemiology. Recurrent topics in Ivan Kruljac's work include Neuroendocrine Tumor Research Advances (5 papers), Lung Cancer Research Studies (4 papers) and Diabetes and associated disorders (4 papers). Ivan Kruljac is often cited by papers focused on Neuroendocrine Tumor Research Advances (5 papers), Lung Cancer Research Studies (4 papers) and Diabetes and associated disorders (4 papers). Ivan Kruljac collaborates with scholars based in Croatia, Italy and Austria. Ivan Kruljac's co-authors include Milan Vrkljan, Mario Štefanović, Hrvoje Ivan Pećina, Marko Lucijanić, Ulrich‐Frank Pape, Ivana Ćelap, Leo Pažanin, Darko Kaštelan, Velimir Božikov and Zvonko Kusić and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Ivan Kruljac

24 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan Kruljac Croatia 8 60 55 36 36 26 25 183
Zafer Pekkolay Türkiye 7 64 1.1× 41 0.7× 30 0.8× 20 0.6× 55 2.1× 36 167
Katharina Artinger Austria 10 49 0.8× 36 0.7× 44 1.2× 31 0.9× 46 1.8× 21 274
Daniela Cugino Italy 7 78 1.3× 34 0.6× 22 0.6× 39 1.1× 55 2.1× 8 272
J.C. Netelenbos Netherlands 9 22 0.4× 76 1.4× 29 0.8× 43 1.2× 23 0.9× 16 263
Riddhishkumar Shah United States 5 47 0.8× 32 0.6× 21 0.6× 16 0.4× 101 3.9× 9 204
Eduardo Ferrero Herrero Spain 11 64 1.1× 23 0.4× 111 3.1× 26 0.7× 33 1.3× 42 245
Takafumi Yamashita Japan 11 31 0.5× 91 1.7× 65 1.8× 69 1.9× 59 2.3× 50 316
Virginie Grouthier France 7 88 1.5× 100 1.8× 42 1.2× 35 1.0× 61 2.3× 23 284
Keisho Hirota Japan 10 125 2.1× 82 1.5× 39 1.1× 89 2.5× 74 2.8× 19 330

Countries citing papers authored by Ivan Kruljac

Since Specialization
Citations

This map shows the geographic impact of Ivan Kruljac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Kruljac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Kruljac more than expected).

Fields of papers citing papers by Ivan Kruljac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Kruljac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Kruljac. The network helps show where Ivan Kruljac may publish in the future.

Co-authorship network of co-authors of Ivan Kruljac

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Kruljac. A scholar is included among the top collaborators of Ivan Kruljac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Kruljac. Ivan Kruljac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kruljac, Ivan, et al.. (2023). The role of the NY-ESO-1 in the prognosis of gastric cancer. SHILAP Revista de lepidopterología. 24(4). 813–820.
3.
Kruljac, Ivan, et al.. (2021). Influence of Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in early-stage HER2 positive breast cancer. Scientific Reports. 11(1). 14395–14395. 3 indexed citations
4.
Murgić, Jure, Amit Bahl, Pierfrancesco Franco, et al.. (2021). Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience. Radiation Oncology. 16(1). 88–88. 3 indexed citations
5.
Kruljac, Ivan, et al.. (2021). Expression of NEDD9 and connexin-43 in neoplastic and stromal cells of gastric adenocarcinoma. Bosnian Journal of Basic Medical Sciences. 21(5). 542–548. 7 indexed citations
6.
Kruljac, Ivan, et al.. (2019). Dose-volume derived nomogram as a reliable predictor of radiotherapy-induced hypothyroidism in head and neck cancer patients. Radiology and Oncology. 53(4). 488–496. 13 indexed citations
7.
8.
Kruljac, Ivan, et al.. (2018). The Role of the Acute Octreotide Suppression Test in Detecting Patients with Neuroendocrine Neoplasms. Neuroendocrinology. 107(3). 284–291. 1 indexed citations
9.
Krušlin, Božo, et al.. (2018). Expression of LMO2 in Prostate Carcinoma and Adjacent Prostatic Parenchyma.. SHILAP Revista de lepidopterología. 57(Suppl 1). 56–60. 1 indexed citations
10.
Kruljac, Ivan, Sebastian Maasberg, Kristina Blaslov, et al.. (2018). A score derived from routine biochemical parameters increases the diagnostic accuracy of chromogranin A in detecting patients with neuroendocrine neoplasms. Endocrine. 60(3). 395–406. 4 indexed citations
11.
Kruljac, Ivan & Ulrich‐Frank Pape. (2017). The classification of neuroendocrine neoplasms: “Neuroendocrine carcinomas” revisited – a 2017 update and future perspectives. SHILAP Revista de lepidopterología. 5 indexed citations
12.
Kruljac, Ivan, et al.. (2017). The role of adipokines as prognostic factors of one-year mortality in hip fracture patients. Osteoporosis International. 28(8). 2475–2483. 8 indexed citations
13.
Kruljac, Ivan, et al.. (2017). The Impact of Hyperosmolarity on Long-Term Outcome in Patients Presenting with Severe Hyperglycemic Crisis: A Population Based Study. Experimental and Clinical Endocrinology & Diabetes. 126(9). 564–569. 7 indexed citations
14.
15.
Kruljac, Ivan, Nina Dabelić, Marko Nikolić, et al.. (2016). Duodenal neuroendocrine tumors (d-NETs): challenges in diagnosis and treatment. SHILAP Revista de lepidopterología. 2(3). 174–193. 4 indexed citations
16.
Lucijanić, Marko, et al.. (2016). Clinical and prognostic significance of anisocytosis measured as a red cell distribution width in patients with colorectal cancer. QJM. 110(6). hcw223–hcw223. 28 indexed citations
17.
Kruljac, Ivan, et al.. (2016). Tyrosine kinase inhibitors and hypothyroidism – an intriguing link. SHILAP Revista de lepidopterología. 2(2). 102–113. 3 indexed citations
18.
Kruljac, Ivan, et al.. (2015). Pleural and pericardial effusions combined with ascites in a patient with severe sunitinib-induced hypothyroidism. Acta Clinica Belgica. 71(3). 175–177. 9 indexed citations
19.
Kruljac, Ivan, et al.. (2015). Advanced Age, High β-CTX Levels, and Impaired Renal Function are Independent Risk Factors for All-Cause One-Year Mortality in Hip Fracture Patients. Calcified Tissue International. 98(1). 67–75. 20 indexed citations
20.
Kruljac, Ivan, et al.. (2012). Pituitary Metastasis Presenting as Ischemic Pituitary Apoplexy Following Heparin-induced Thrombocytopenia. Endocrine Pathology. 23(4). 264–267. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zafer Pekkolay Breakdown of academic impact, for papers by Katharina Artinger Breakdown of academic impact, for papers by Daniela Cugino Breakdown of academic impact, for papers by J.C. Netelenbos Breakdown of academic impact, for papers by Riddhishkumar Shah Breakdown of academic impact, for papers by Eduardo Ferrero Herrero Breakdown of academic impact, for papers by Takafumi Yamashita Breakdown of academic impact, for papers by Virginie Grouthier Breakdown of academic impact, for papers by Keisho Hirota
Rankless by CCL
2026